Cita APA

Schniewind, B., Heintz, K., Kurdow, R., Ammerpohl, O., Trauzold, A., Emme, D., . . . Kalthoff, H. (2006). Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. BioMed Central.

Chicago Style Citation

Schniewind, Bodo, Kirsten Heintz, Roland Kurdow, Ole Ammerpohl, Anna Trauzold, Doris Emme, Peter Dohrmann, i Holger Kalthoff. Combination Phenylbutyrate/gemcitabine Therapy Effectively Inhibits in Vitro and in Vivo Growth of NSCLC By Intrinsic Apoptotic Pathways. BioMed Central, 2006.

Cita MLA

Schniewind, Bodo, et al. Combination Phenylbutyrate/gemcitabine Therapy Effectively Inhibits in Vitro and in Vivo Growth of NSCLC By Intrinsic Apoptotic Pathways. BioMed Central, 2006.